My Story…
Did you know that only four per cent of all cancer research funding in Canada goes toward pediatric cancers? Yet it’s the number one cause of death by disease in kids. We can do better for them and for our collective future.
Exactly one year ago, my then 5-year-old daughter Sloane, who was supposed to be running in the kids’ marathon at this very race, was instead diagnosed with stage 4 neuroblastoma - CANCER. Despite the challenges she's faced, Sloane's spirit, resilience, energy and infectious laughter have inspired me to take action.
As a runner myself, I thought what a great way to increase awareness for childhood cancer, raise valuable dollars for research and have a darn good time with some awesome people while we are at it!
On May 26, 2024, we will be participating in the annual Calgary marathon, not just as a physical challenge but as a symbol of hope, strength, and solidarity for children like Sloane. We have set an ambitious fundraising goal, and this is where we need your help.
Your contribution can make a meaningful impact on the lives of children battling cancer through the Alberta Children's Hospital Foundation's contribution to the new Centre for Immunotherapy. Every dollar brings us one step closer to advancements in treatment, research breakthroughs, and ultimately, a cure. It is our collective responsibility to ensure that children like Sloane can grow up to live long, healthy, happy lives.
Make a donation. Make some noise. Make a difference.
Donate to help Claire raise money for Servus Calgary Marathon 2024’s fundraising campaign.
Recent donors
Donation date | Donor name | Donation amount |
---|---|---|
Apr 13 | Anonymous | $535.02 |
Apr 13 | Scott and Amy Sharpe | Undisclosed amount |
Apr 12 | Anonymous | Undisclosed amount |
Apr 09 | Strong Like Sloane | $27.60 |
Apr 09 | Anonymous | Undisclosed amount |
Apr 01 | Donald Richard | $107.72 |
Mar 28 | Family of Matthew Little | $1,069.14 |
Mar 27 | Rob Sprinkhuysen | $107.72 |
Mar 27 | Ann Newton | $27.60 |
Mar 27 | Carleigh Parrell | Undisclosed amount |